Why CNS Pharmaceuticals Shares Are Getting Hammered
Why CNS Pharmaceuticals Shares Are Getting Hammered
CNS Pharmaceuticals, Inc (NASDAQ:CNSP) shares are trading lower by 33.4% to $0.14 during Monday's session after the company announced a 1-for-50 reverse split of its common stock, effective at 4:01 PM ET on June 4. This move aims to increase the share price and meet Nasdaq's minimum share price requirement.
CNS製藥公司（納斯達克：CNSP）股票在週一交易中下跌33.4％至0.14美元，這是在該公司宣佈其普通股進行一比五十的逆向股份分割生效之後的結果，生效時間爲6月4日下午4:01 ET。此舉旨在提高股價並滿足納斯達克的最低股價要求。
In the reverse split, every 50 shares of common stock will be consolidated into one share. Warrants, equity-based awards, and other equity rights will be adjusted accordingly. Fractional shares will not be issued; instead, any fractional share entitlement will be rounded up to the nearest whole share.
在股份分割中，每50股普通股將合併爲一股。權證、以股票爲基礎的獎勵和其他股權都將相應地進行調整。將不發行碎股，而是將所有碎股權益向上舍入至最接近的整股。
The par value of the common stock remains at $0.001 per share, and the authorized shares stay at 300 million. The reverse split will uniformly affect all stockholders without changing any stockholder's ownership percentage, except for rounding adjustments.
普通股的面值仍爲每股0.001美元，授權股份數量保持在3億股。股份分割將統一影響所有股東，而不會改變任何股東的所有權百分比，除了向上舍入的調整。
Should I Sell My CNSP Stock?
我應該賣掉我的CNSP股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮他們的投資期限、未實現收益和總回報。
Shares of CNS Pharma have decreased by 93.88% in the past year. An investor who bought shares of CNS Pharma at the beginning of the year would take a loss of $1.04 per share if they sold it today. The stock has fallen 28.17% over the past month, meaning an investor who bought shares on May. 1 would see a capital loss of $0.07.
CNS Pharma的股價在過去一年中下降了93.88％。如果投資者今天出售，則在今年年初購買CNS Pharma股票的投資者將每股蒙受1.04美元的虧損。該股在過去一個月中下跌了28.17％，這意味着在5月1日購買股票的投資者將蒙受0.07美元的資本虧損。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. CNS Pharma stock currently has an RSI of 55.04, indicating neutral conditions.
投資者還可以考慮市場動態。相對強度指數可用於指示股票是否超買或超賣。CNS Pharma的股票目前的RSI爲55.04，表明中立情況。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
獲取先進的圖表和分析工具以及股票數據，請查看Benzinga PRO。免費試用。
CNSP has a 52-week high of $2.91 and a 52-week low of $0.14.
CNSP的52周高點爲2.91美元，52周低點爲0.14美元。
譯文內容由第三人軟體翻譯。